Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J McNatt

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
The American Journal of Cardiology|January 25, 1991
Role of new antiplatelet agents as adjunctive therapies in thrombolysisJ T Willerson, P Golino, J McNatt, et al.
Circulation|March 1, 1988
Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosisP Golino, J H Ashton, P Glas-Greenwalt, et al.
The Journal of Clinical Investigation|October 1, 1990
Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosisP Golino, M Rosolowsky, S K Yao, et al.
Circulation|December 1, 1993
Combined ADP and thromboxane A2 antagonism prevents cyclic flow variations in stenosed and endothelium-injured arteries in nonhuman primatesS K Yao, J McNatt, K Cui, et al.
The Journal of Clinical Investigation|July 1, 1989
Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injuryJ F Eidt, P Allison, S Noble, et al.
Journal of the American College of Cardiology|May 1, 1991
Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injuryJ T Willerson, J F Eidt, J McNatt, et al.
Journal of the American College of Cardiology|July 1, 1985
Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemiaG D Tilton, L M Buja, D W Bilheimer, et al.
Circulation|April 1, 1994
Liposome-bound prostaglandin E1 often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteriesJ T Willerson, S K Yao, J McNatt, et al.
Journal of Molecular and Cellular Cardiology|April 1, 1991
Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosisS K Yao, C R Benedict, M Rosolowsky, et al.
Circulation|September 1, 1993
Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregationP Golino, G Ambrosio, M Ragni, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The American Journal of Cardiology|January 25, 1991
Role of new antiplatelet agents as adjunctive therapies in thrombolysisJ T Willerson, P Golino, J McNatt, et al.
Circulation|March 1, 1988
Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosisP Golino, J H Ashton, P Glas-Greenwalt, et al.
The Journal of Clinical Investigation|October 1, 1990
Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosisP Golino, M Rosolowsky, S K Yao, et al.
Circulation|December 1, 1993
Combined ADP and thromboxane A2 antagonism prevents cyclic flow variations in stenosed and endothelium-injured arteries in nonhuman primatesS K Yao, J McNatt, K Cui, et al.
The Journal of Clinical Investigation|July 1, 1989
Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injuryJ F Eidt, P Allison, S Noble, et al.
Journal of the American College of Cardiology|May 1, 1991
Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injuryJ T Willerson, J F Eidt, J McNatt, et al.
Journal of the American College of Cardiology|July 1, 1985
Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemiaG D Tilton, L M Buja, D W Bilheimer, et al.
Circulation|April 1, 1994
Liposome-bound prostaglandin E1 often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteriesJ T Willerson, S K Yao, J McNatt, et al.
Journal of Molecular and Cellular Cardiology|April 1, 1991
Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosisS K Yao, C R Benedict, M Rosolowsky, et al.
Circulation|September 1, 1993
Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregationP Golino, G Ambrosio, M Ragni, et al.
Pageof 3